Azithromycin Added to Standard Therapy for P. Aeruginosa Infection Reduces Lung Exacerbations, Trial Finds

Azithromycin Added to Standard Therapy for P. Aeruginosa Infection Reduces Lung Exacerbations, Trial Finds

JULY 10, 2018

BY IQRA MUMAL

 

IN CYSTIC FIBROSIS, NEWS.

Adding azithromycin to the standard antibiotic treatment for early Pseudomonas aeruginosa infections is associated with fewer pulmonary exacerbations in children with cystic fibrosis (CF), results from a Phase 3 trial show. Trial findings were published in the study, “Azithromycin for Early Pseudomonas Infection in Cystic Fibrosis: The Optimize Randomized Trial,” in the American Journal of Respiratory […] The post Azithromycin Added to Standard Therapy for P. Aeruginosa Infection Reduces Lung Exacerbations, Trial Finds appeared first on Cystic Fibrosis News Today.

Read More